COSMEGEN
\kˈɒzmɛd͡ʒən], \kˈɒzmɛdʒən], \k_ˈɒ_z_m_ɛ_dʒ_ə_n]\
Sort: Oldest first
-
An antitumor antibiotic derived from Streptomyces parvullus. It binds to DNA and inhibits RNA synthesis (transcription), with chain elongation more sensitive than initiation, termination, or release. As a result of impaired mRNA production, protein synthesis also declines after dactinomycin therapy. (From AMA Drug Evaluations Annual, 1993, p2015)
By DataStellar Co., Ltd
